FDA advisors back updating COVID shots to monovalent XBB-lineage

A panel of FDA advisors voted 21 to 0 to recommend that the 2023-2024 formula of COVID-19 vaccines in the U.S be updated to a monovalent XBB-lineage, according to multiple media reports covering the advisory committee meeting.